SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-052721
Filing Date
2023-10-10
Accepted
2023-10-10 17:43:17
Documents
1
Period of Report
2023-10-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3293
  Complete submission text file 0000950170-23-052721.txt   4784
Mailing Address ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Pottage John C Jr (Reporting) CIK: 0001378587 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38266 | Film No.: 231318946

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations